Judge Edward M. Chen narrowed the allegations against Teva, one of several pharmaceutical companies accused of taking a “reverse payment” from Gilead to shelve its generic version of Truvada as part of a settlement resolving patent infringement litigation.
“Reverse payment” settlements—so called because they involve concessions from a patent plaintiff to a defendant, rather than in the usual ...